Ignite Creation Date:
2024-05-06 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 2:27 PM
Study NCT ID:
NCT05279859
Status:
WITHDRAWN
Last Update Posted:
2022-06-15
First Post:
2022-03-05
Brief Title:
A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Hematologic Malignancies
Sponsor:
Erasca Inc
Organization:
Erasca Inc